Blockade of both B7-H4 and CTLA-4 co-signaling pathways enhances mouse islet allograft survival

References

• Adams AB, Shirasugi N, Durham MM, Strobert E, Anderson D, Rees P, et al. Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. Diabetes 2002; 51:265 - 70; http://dx.doi.org/10.2337/diabetes.51.2.265; PMID: 11812731
   PubMed Web of Science ®Google Scholar
• Arefanian H, Tredget EB, Rajotte RV, Gill RG, Korbutt GS, Rayat GR. Short-term administrations of a combination of anti-LFA-1 and anti-CD154 monoclonal antibodies induce tolerance to neonatal porcine islet xenografts in mice. Diabetes 2010; 59:958 - 66; http://dx.doi.org/10.2337/db09-0413; PMID: 20086231
   PubMed Web of Science ®Google Scholar
• Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, et al. A new member of the immunoglobulin superfamily--CTLA-4. Nature 1987; 328:267 - 70; http://dx.doi.org/10.1038/328267a0; PMID: 3496540
   PubMed Web of Science ®Google Scholar
• Choi IH, Zhu G, Sica GL, Strome SE, Cheville JC, Lau JS, et al. Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family. J Immunol 2003; 171:4650 - 4; PMID: 14568939
   PubMed Web of Science ®Google Scholar
• Fan X, Tyerman K, Ang A, Koo K, Parameswaran K, Tao K, et al. A novel tool for B-cell tolerance research: characterization of mouse alloantibody development using a simple and reliable cellular ELISA technique. Transplant Proc 2005; 37:29 - 31; http://dx.doi.org/10.1016/j.transproceed.2004.12.119; PMID: 15808536
   PubMed Web of Science ®Google Scholar
• Grohmann U, Orabona C, Fallarino F, Vacca C, Calcinaro F, Falorni A, et al. CTLA-4-Ig regulates tryptophan catabolism in vivo. Nat Immunol 2002; 3:1097 - 101; http://dx.doi.org/10.1038/ni846; PMID: 12368911
   PubMed Web of Science ®Google Scholar
• Guo L, Li XK, Funeshima N, Fujino M, Nagata Y, Kimura H, et al. Prolonged survival in rat liver transplantation with mouse monoclonal antibody against an inducible costimulator (ICOS). Transplantation 2002; 73:1027 - 32; http://dx.doi.org/10.1097/00007890-200204150-00003; PMID: 11965027
   PubMed Web of Science ®Google Scholar
• Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997; 94:8789 - 94; http://dx.doi.org/10.1073/pnas.94.16.8789; PMID: 9238056
   PubMed Web of Science ®Google Scholar
• Laumonier T, Potiron N, Boeffard F, Chagneau C, Brouard S, Guillot C, et al. CTLA4Ig adenoviral gene transfer induces long-term islet rat allograft survival, without tolerance, after systemic but not local intragraft expression. Hum Gene Ther 2003; 14:561 - 75; http://dx.doi.org/10.1089/104303403764539341; PMID: 12718766
   PubMed Web of Science ®Google Scholar
• Lenschow DJ, Zeng Y, Thistlethwaite JR, Montag A, Brady W, Gibson MG, et al. Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg. Science 1992; 257:789 - 92; http://dx.doi.org/10.1126/science.1323143; PMID: 1323143
   PubMed Web of Science ®Google Scholar
• Li Y, Ma L, Shen J, Chong AS. Peripheral deletion of mature alloreactive B cells induced by costimulation blockade. Proc Natl Acad Sci U S A 2007; 104:12093 - 8; http://dx.doi.org/10.1073/pnas.0705240104; PMID: 17609366
   PubMed Web of Science ®Google Scholar
• Linsley PS, Wallace PM, Johnson J, Gibson MG, Greene JL, Ledbetter JA, et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992; 257:792 - 5; http://dx.doi.org/10.1126/science.1496399; PMID: 1496399
   PubMed Web of Science ®Google Scholar
• Miao G, Ito T, Uchikoshi F, Akamaru Y, Kiyomoto T, Komodo H, et al. Development of donor-specific immunoregulatory T-cells after local CTLA4Ig gene transfer to pancreatic allograft. Transplantation 2004; 78:59 - 64; http://dx.doi.org/10.1097/01.TP.0000128330.64007.85; PMID: 15257039
   PubMed Web of Science ®Google Scholar
• Mirenda V, Golshayan D, Read J, Berton I, Warrens AN, Dorling A, et al. Achieving permanent survival of islet xenografts by independent manipulation of direct and indirect T-cell responses. Diabetes 2005; 54:1048 - 55; http://dx.doi.org/10.2337/diabetes.54.4.1048; PMID: 15793243
   PubMed Web of Science ®Google Scholar
• Nanji SA, Hancock WW, Anderson CC, Adams AB, Luo B, Schur CD, et al. Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival. Am J Transplant 2004; 4:526 - 36; http://dx.doi.org/10.1111/j.1600-6143.2004.00384.x; PMID: 15023144
   PubMed Web of Science ®Google Scholar
• Nanji SA, Hancock WW, Luo B, Schur CD, Pawlick RL, Zhu LF, et al. Costimulation blockade of both inducible costimulator and CD40 ligand induces dominant tolerance to islet allografts and prevents spontaneous autoimmune diabetes in the NOD mouse. Diabetes 2006; 55:27 - 33; http://dx.doi.org/10.2337/diabetes.55.01.06.db04-1154; PMID: 16380473
   PubMed Web of Science ®Google Scholar
• Ou D, Wang X, Metzger DL, Ao Z, Pozzilli P, James RF, et al. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Cell Transplant 2006; 15:399 - 410; http://dx.doi.org/10.3727/000000006783981837; PMID: 16970282
   PubMed Web of Science ®Google Scholar
• Potiron N, Chagneau C, Boeffard F, Soulillou JP, Anegon I, Le Mauff B. Adenovirus-mediated CTLA4Ig or CD40Ig gene transfer delays pancreatic islet rejection in a rat-to-mouse xenotransplantation model after systemic but not local expression. Cell Transplant 2005; 14:263 - 75; http://dx.doi.org/10.3727/000000005783983052; PMID: 16052908
   PubMed Web of Science ®Google Scholar
• Prasad DV, Richards S, Mai XM, Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003; 18:863 - 73; http://dx.doi.org/10.1016/S1074-7613(03)00147-X; PMID: 12818166
   PubMed Web of Science ®Google Scholar
• Salama AD, Yuan X, Nayer A, Chandraker A, Inobe M, Uede T, et al. Interaction between ICOS-B7RP1 and B7-CD28 costimulatory pathways in alloimmune responses in vivo. Am J Transplant 2003; 3:390 - 5; http://dx.doi.org/10.1034/j.1600-6143.2003.00085.x; PMID: 12694060
   PubMed Web of Science ®Google Scholar
• Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343:230 - 8; http://dx.doi.org/10.1056/NEJM200007273430401; PMID: 10911004
   PubMed Web of Science ®Google Scholar
• Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 2006; 355:1318 - 30; http://dx.doi.org/10.1056/NEJMoa061267; PMID: 17005949
   PubMed Web of Science ®Google Scholar
• Sica GL, Choi IH, Zhu G, Tamada K, Wang SD, Tamura H, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003; 18:849 - 61; http://dx.doi.org/10.1016/S1074-7613(03)00152-3; PMID: 12818165
   PubMed Web of Science ®Google Scholar
• Stegall MD, Raghavaiah S, Gloor JM. The (re)emergence of B cells in organ transplantation. Curr Opin Organ Transplant 2010; 15:451 - 5; http://dx.doi.org/10.1097/MOT.0b013e32833b9c11; PMID: 20613525
   PubMed Web of Science ®Google Scholar
• Suh WK, Wang S, Duncan GS, Miyazaki Y, Cates E, Walker T, et al. Generation and characterization of B7-H4/B7S1/B7x-deficient mice. Mol Cell Biol 2006; 26:6403 - 11; http://dx.doi.org/10.1128/MCB.00755-06; PMID: 16914726
   PubMed Web of Science ®Google Scholar
• Tarumi K, Murakami M, Yagihashi A, Nakagawa I, Hirata K, Uede T. CTLA4IgG treatment induces long-term acceptance of rat small bowel allografts. Transplantation 1999; 67:520 - 5; http://dx.doi.org/10.1097/00007890-199902270-00005; PMID: 10071020
   PubMed Web of Science ®Google Scholar
• Truong W, Hancock WW, Anderson CC, Merani S, Shapiro AM. Coinhibitory T-cell signaling in islet allograft rejection and tolerance. Cell Transplant 2006; 15:105 - 19; http://dx.doi.org/10.3727/000000006783982160; PMID: 16719045
   PubMed Web of Science ®Google Scholar
• Vincenti F, Larsen C, Durrbach A, Wekerle T, Nashan B, Blancho G, et al, Belatacept Study Group. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005; 353:770 - 81; http://dx.doi.org/10.1056/NEJMoa050085; PMID: 16120857
   PubMed Web of Science ®Google Scholar
• Vincenti F, Charpentier B, Vanrenterghem Y, Rostaing L, Bresnahan B, Darji P, et al. A phase III study of belatacept-based immunosuppression regimens versus cyclosporine in renal transplant recipients (BENEFIT study). Am J Transplant 2010; 10:535 - 46; http://dx.doi.org/10.1111/j.1600-6143.2009.03005.x; PMID: 20415897
   PubMed Web of Science ®Google Scholar
• Wang X, Hao J, Metzger DL, Mui A, Ao Z, Verchere CB, et al. Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival. Transplantation 2009; 87:482 - 90; http://dx.doi.org/10.1097/TP.0b013e318195e5fa; PMID: 19307783
   PubMed Web of Science ®Google Scholar
• Wang X., Hao J., Metzger D. L., Mui A., Ao Z., Verchere C. B., Chen L., Ou D., Warnock G. L.. B7-H4 induces donor-specific tolerance in mouse islet allografts. Cell Transplant 2011; In press PMID: 21929869
   PubMed Web of Science ®Google Scholar
• Wang X, Hao J, Metzger DL, Mui A, Ao Z, Akhoundsadegh N, et al. Early treatment of NOD mice with B7-H4 reduces the incidence of autoimmune diabetes. Diabetes 2011; 60:3246 - 55; http://dx.doi.org/10.2337/db11-0375; PMID: 21984581
   PubMed Web of Science ®Google Scholar
• Warnock GL, Meloche RM, Thompson D, Shapiro RJ, Fung M, Ao Z, et al. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. Arch Surg 2005; 140:735 - 44; http://dx.doi.org/10.1001/archsurg.140.8.735; PMID: 16103282
   PubMed Web of Science ®Google Scholar
• Warnock GL, Liao YH, Wang X, Ou D, Ao Z, Johnson JD, et al. An odyssey of islet transplantation for therapy of type 1 diabetes. World J Surg 2007; 31:1569 - 76; http://dx.doi.org/10.1007/s00268-007-9125-0; PMID: 17562107
   PubMed Web of Science ®Google Scholar
• Waterhouse P, Penninger JM, Timms E, Wakeham A, Shahinian A, Lee KP, et al. Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 1995; 270:985 - 8; http://dx.doi.org/10.1126/science.270.5238.985; PMID: 7481803
   PubMed Web of Science ®Google Scholar
• Wei J, Duramad O, Perng OA, Reiner SL, Liu YJ, Qin FX. Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 2007; 104:18169 - 74; http://dx.doi.org/10.1073/pnas.0703642104; PMID: 17978190
   PubMed Web of Science ®Google Scholar
• Yamada A, Konishi K, Cruz GL, Takehara M, Morikawa M, Nakagawa I, et al. Blocking the CD28-B7 T-cell costimulatory pathway abrogates the development of obliterative bronchiolitis in a murine heterotopic airway model. Transplantation 2000; 69:743 - 9; http://dx.doi.org/10.1097/00007890-200003150-00012; PMID: 10755520
   PubMed Web of Science ®Google Scholar
• Yamaura K, Watanabe T, Boenisch O, Yeung M, Yang S, Magee CN, et al. In vivo function of immune inhibitory molecule B7-H4 in alloimmune responses. Am J Transplant 2010; 10:2355 - 62; http://dx.doi.org/10.1111/j.1600-6143.2010.03250.x; PMID: 21143433
   PubMed Web of Science ®Google Scholar
• Yuan CL, Xu JF, Tong J, Yang H, He FR, Gong Q, et al. B7-H4 transfection prolongs beta-cell graft survival. Transpl Immunol 2009; 21:143 - 9; http://dx.doi.org/10.1016/j.trim.2009.03.007; PMID: 19361556
   PubMed Web of Science ®Google Scholar
• Zang X, Loke P, Kim J, Murphy K, Waitz R, Allison JP. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci U S A 2003; 100:10388 - 92; http://dx.doi.org/10.1073/pnas.1434299100; PMID: 12920180
   PubMed Web of Science ®Google Scholar